<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table2" position="float"><label>Table 2.</label><caption><title>Treatment and parasitological data per study group.</title></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th valign="top">LD-SP/SP</th><th valign="top">LD-SP/PIP</th><th valign="top">LD-PIP/PIP</th><th valign="top">LD-PIP/SP</th></tr></thead><tbody><tr><td>Time to T1 (<italic>days</italic>)</td><td>Median (range)</td><td>13 (9.3&#8211;12.8)</td><td>10.8 <break/>(0.8&#8211;11.8)</td><td>10.3 <break/>(10.3&#8211;12.3)</td><td>12.8 <break/>(12.3&#8211;14.3)</td></tr><tr><td>Time between T1-T2 (<italic>days</italic>)</td><td>Median (range)</td><td>9.1 <break/>(7.7&#8211;11.7)</td><td>10 (9.2&#8211;10.2)</td><td>4.7 (2&#8211;10.7)</td><td>2.5 <break/>(1.5&#8211;5.0)</td></tr><tr><td>Area under the curve (AUC)*</td><td>Median (range)</td><td/><td/><td/><td/></tr><tr><td>&#160;Asexual</td><td/><td>6490 (1120&#8211;16337)</td><td>13280 (2773&#8211;43777)</td><td>14347 (5408&#8211;24898)</td><td>12747 (4572&#8211;82973)</td></tr><tr><td>&#160;Sexual</td><td/><td>280 (27&#8211;3640)</td><td>271 (64&#8211;848)</td><td>784 (316&#8211;1274)</td><td>6624 (1515&#8211;10244)</td></tr><tr><td>Peak parasite density (<italic>Pf</italic>/mL)</td><td>Median (range)</td><td>6467 (1050&#8211;20261)</td><td>16376 (2590&#8211;50210)</td><td>11603 (2408&#8211;21565)</td><td>8491 (3976&#8211;63113)</td></tr><tr><td>Peak gametocyte density (gct/mL)</td><td>Median (range)</td><td>38 (11&#8211;368)</td><td>30 (13&#8211;101)</td><td>83 (46&#8211;99)</td><td>627 (199&#8211;1285)</td></tr><tr><td>Day of gametocyte detection after infection (days)</td><td>Mean (SD)</td><td>18.3 (1.0)</td><td>18.5 (1.0)</td><td>17.3 (1.5)</td><td>19.4 (1.3)</td></tr><tr><td>Time to gametocyte detection relative to first asexual parasites<sup>&#8224;</sup> (days)</td><td>Mean (SD)</td><td>10.5 (1.3)</td><td>11.5 (1.0)</td><td>10.1 (1.3)</td><td>10.1 (1.2)</td></tr><tr><td>Proportion of days gametocyte positive (%)<sup>&#8225;</sup></td><td>Mean (SD)</td><td>27.4 (6.7)</td><td>35.9 (7.6)</td><td>51.4 (7.9)</td><td>48.3 (8.1)</td></tr><tr><td>Duration gametocytemia<sup>&#167;</sup> (days)</td><td>Median (range)</td><td>7.5&#160;(1&#8211;24)</td><td>6 (2&#8211;14)</td><td>17 (12&#8211;25)</td><td>24.5 (17&#8211;25)</td></tr></tbody></table><table-wrap-foot><fn><p><sup>*</sup>The area under the curve (AUC) represents the total parasite exposure over time (asexual- or sexual parasite load).</p><p><sup>&#8224;</sup>Time to gametocyte detection is calculated as the day of the detection of gametocytes (&#8805;5 gct/mL) minus the day of first peak asexual parsitaemia.</p></fn><fn><p><sup>&#8225;</sup>The proportion of gametocyte positive days is calculated as all days with&#160;&#8805;5 gct/mL by Pfs25-qRT-PCR divided by all days where Pfs25 qRT-PCR was performed.</p><p><sup>&#167;</sup>Maximum number of consecutive days of <italic>Pfs25</italic> qRT-PCR measured gametocytemia&#160;&#8805;5 gct/mL.</p></fn></table-wrap-foot></table-wrap>